Demographic feature | Value |
---|---|
Bladder cancer | |
Number of patients: | Â |
SBT | 45 (53.57%) |
NSBT | 39 (46.43%) |
Sex of patients: | Â |
SBT | 38 men and 7 women |
NSBT | 25 men and 14 women |
Recurrence of bladder cancer: | Â |
First presentation | 61 (72.62%) |
Recurrent | 23 (27.38%) |
Age of patients: | Â |
SBT | Range: 38–64 years, mean: 51.4 ± 6.2 years |
NSBT | Range: 46–72, mean: 66.5 ± 5.3 years |
Type of tumor growth: | Â |
SBT | 37 papillary 8 sessile |
NSBT | 34 papillary 4 sessile 1 nodular |
Tumor muscle invasiveness: | Â |
Invasive (T2, T3, and T4) | 62 (73.81%) patients |
Non invasive (Ta, T1, and CIS) | 22 (26.19%) patients |
Grading: | Â |
Low grade (grade 1 and 2) | 35 (41.66%) patients |
High grade (grade 3) | 49 (58.33%) patients |
Histopathology of bladder tumors: | Â |
SCC | 52 (61.91%) patients |
TCC | 32 (38.09%) patients |
Staging of bladder cancer patients: | Â |
Stage I | 9 (10.71%) |
Stage II | 13 (15.47%) |
Stage III | 18 (21.42%) |
Stage IV | 44 (52.38%) |
Chronic cystitis | |
Number of patients: | Â |
SC | 16 (36.36%) |
NSC | 28 cases (63.64%) |
Sex of patients: | Â |
SC | 14 men and 2 women |
NSC | 15 men and 13 women |
Age of patients: | Â |
SC | mean age 62.5 ± 3.5 years |
NSC | mean age 53.4 ± 4.2 years |